Our study was carried out at Robert BALLANGER Hospital, its aim was to determine the contribution of the scanner in the diagnosis of COVID-19. It was a prospective descriptive study during the first wave of the COVID-19 epidemic in France. Patients were referred to the medical imaging department for a thoracic CT scan without contrast injection or an angioscanner in the context of a suspected COVID-19 pneumopathy or pulmonary embolism. The study involved both sexes, the male sex was with 55.20% and sex ratio of 1.24. In our study 50% of our patients had a comorbid factor, of which diabetes and hypertension were the most represented with 33% and 17%. The RT PRC test is considered the gold standard in the diagnosis of COVID-19 disease. This test was positive in 63.62% of our patients. CT imaging played a key role in the management of COVID-19 pneumonia because chest CT scans found lesions consistent with COVID-19 pneumonia in 71% of patients. The depoliated lung lesion was present in 87% of our patients, with sub pleural topography and minimal parenchymal involvement predominating. In our study, the chest CT scan had a higher sensitivity and a lower specificity than the PCR test.
References
[1]
WMHC (2020) The Wuhan Municipal Health and Welfare Commission’s Briefing on the Current Situation of the Pneumonia Epidemic in Our City.
http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
[2]
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020) Early Transmission Dynamics in Wuhan, China, of New Coronavirus-Infected Pneumonia. The New England Journal of Medicine, 382, 1199-1207.
https://doi.org/10.1056/NEJMoa2001316
[3]
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. (2020) A Novel Coronavirus of Pneumonia Patients in China, 2019. The New England Journal of Medicine, 382, 727-733. https://doi.org/10.1056/NEJMoa2001017
[4]
Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5
https://www.sciencedirect.com/science/article/pii/S0140673620301835
[5]
Yang, W.J., Sirajuddin, A., Zhang, X.C., Liu, G.S., Teng, Z.Z., Zhao, S.H. and Lu, M.J. (2020) The Role of Imaging in 2019 Novel Coronavirus Pneumonia (COVID-19). European Radiology, 30, 4874-4882. https://doi.org/10.1007/s00330-020-06827-4
[6]
Jin, Y.H., Cai, L., Cheng, Z.S., Cheng, H., Deng, T., Fan, Y.P., et al. (2020) A Rapid Advice Guideline for the Diagnosis and Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia (Standard Version). Military Medical Research, 7, Article No. 4. https://doi.org/10.1186/s40779-020-0233-6
[7]
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., et al. (2020) Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 180, 934-943. https://doi.org/10.1001/jamainternmed.2020.0994
[8]
Gautret, P., Lagier, J.C., Parola, P., Hoang, V.T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Brouqui, P., Raoult, D., et al. (2020) Hydroxychloroquine and Azithromycin as a Treatment for COVID-19: Results of an Open-Label, Non-Randomized Clinical Trial. International Journal of Antimicrobial Agents, 56, Article ID: 105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
[9]
Zheng, Y., Xiong, C., Liu, Y.Q., Qian, X., Tang, Y.J., Liu, L., Leung, E.L.-H. and Wang, M.F. (2020) Epidemiological and Clinical Characteristics Analysis of COVID-19 in the Surrounding Areas of Wuhan, Hubei Province in 2020. Pharmacological Research, 157, Article ID: 104821. https://doi.org/10.1016/j.phrs.2020.104821
[10]
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. The Lancet, 395, 1054-1062.
https://doi.org/10.1016/S0140-6736(20)30566-3
[11]
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G. and Tan, W. (2020) Dectection of SARS-CoV2 in Different Types of Clinical Specimens. JAMA, 323, 1843-1844.
https://doi.org/10.1001/jama.2020.3786
[12]
Million, M., Lagier, J.C., Gautret, P., Colson, P., Fournier, E.P. and Amrane, S. (2020) Early Treatment of Patients with COVID-19 with Hydroxychloroquine and Azithromycin: A Retrospective Analysis of 1061 Cases in Marseille, France. Travel Medicine and Infectious Disease, 35, Article ID: 101738.
https://doi.org/10.1016/j.tmaid.2020.101738
[13]
Ruch, Y., Kaeuffer, C., Ohana, M., Labani, A., Kepka, S., Solis, M., Greigert, V., Lefebvre, N., Hansmann, Y. and Danion, F. (2020) CT Lung Lesions as Predictors of Early Death or ICU Admission in COVID-19 Patients. Clinical Microbiology and Infection, 26, 1417.e5-1417.e8. https://doi.org/10.1016/j.cmi.2020.07.030
[14]
Conan, P., Delattre, C., Zimmermann, H., Gervaise, A., Dubost, C., Leclerc, T., Hegl-Garcia, C., Ficko, C., Doutrelon, C. and Liber, N. (2020) Factors Associated with the Occurrence of Pulmonary Embolism during COVID-19. Médecine et Maladies Infectieuses, 50, S81. https://doi.org/10.1016/j.medmal.2020.06.162
